Skip to search formSkip to main contentSkip to account menu
DOI:10.1108/IJHCQA-02-2019-0042 - Corpus ID: 220499258
@article{Pakdaman2020TheCO, title={The cost-effectiveness of insulin analogs and regular insulin for diabetes control: a case study in Iran.}, author={Mohsen Pakdaman and Raheleh Akbari and Hamid Reza Dehghan and Asra Asgharzadeh and Mahdieh Namayandeh}, journal={International journal of health care quality assurance}, year={2020}, volume={ahead-of-print ahead-of-print}, url={https://api.semanticscholar.org/CorpusID:220499258}}
- M. Pakdaman, R. Akbari, M. Namayandeh
- Published in International Journal of… 14 July 2020
- Medicine, Economics
The present findings suggest that insulin analogs are more cost-effective than regular insulin in controlling diabetes.
1 Citation
One Citation
- Mari PesonenVirpi JylhäE. Kankaanpää
- 2024
Medicine, Economics
JBI evidence synthesis
The inclusion of ADEs in cost-effectiveness models is suboptimal, and the ADE-related costs were better captured than the ADE-related impact on quality of life, which was most pronounced in the models for diabetic retinopathy and diabetic macular edema.
31 References
- M. PakdamanR. AkbariH. DehghanReza ValagoharP. RostamiM. Namayandeh
- 2019
Medicine, Economics
Health Technology Assessment in Action
Although the use of analogue insulin is more expensive for diabetic patients, it is more effective than vial insulin and insurance companies are recommended to develop special plans for the three vulnerable groups of seniors, children, and pregnant women to provide them with analogue insulin.
- M. PfohlP. SchädlichF. DippelK. Koltermann
- 2012
Economics, Medicine
Journal of medical economics
GLA appears to be cost effective or even cost saving among type 1 diabetics with basal bolus therapy from the perspective of SHI compared to NPH depending on the scenario chosen.
- 17
- PDF
- W. ValentineK. van BruntK. BoyeR. Pollock
- 2018
Economics, Medicine
Applied Health Economics and Health Policy
Rapid-acting analog insulin is associated with beneficial outcomes in patients with type 1 diabetes and is likely to be considered cost effective in the German setting vs. regular human insulin.
- 5
- PDF
- U. PermsuwanN. ChaiyakunaprukP. DilokthornsakulK. ThavornSurasak Saokaew
- 2016
Economics, Medicine
Applied Health Economics and Health Policy
Compared to treatment with NPH insulin, treatment with IGlar in type 2 diabetes patients who had uncontrolled blood glucose with oral anti-diabetic drugs did not represent good value for money at the acceptable threshold in Thailand.
- 11
- PDF
- C. MoralesD. D. de LuisA. R. de ArellanoM. FerrarioL. Lizán
- 2015
Economics, Medicine
Diabetes Therapy
IDet was a cost-effective alternative to NPH insulin in the first year of treatment of patients with type 1 diabetes mellitus and patients with T2DM in Spain, with ICERs under the threshold value commonly accepted in Spain (€30,000/QALY).
- 12
- PDF
- Martin RidderstråleMarie Markert JensenRasmus Prior GjesingLeo Niskanen
- 2013
Medicine, Economics
Journal of medical economics
The lower risk of non-severe hypoglycaemia and less weight gain associated with using insulin detemir compared with NPH insulin when initiating insulin treatment in insulin naïve patients with type 2 diabetes provide economic benefits in the short-term.
- 19
- PDF
- Min LiuZhiguang Zhou C. Gong
- 2016
Medicine
BMC Endocrine Disorders
Initiation of insulin glargine can aid Chinese paediatric patients with type 1 diabetes mellitus to safely reduce their HbA1c levels, and both treatments were generally well tolerated.
- 6
- A. BossiG. Veronesi E. Davis
- 2016
Medicine
Current diabetes reviews
A selective use of individual pre-filled pens/safety needles for patients who are likely to continue insulin therapy at home may strongly reduce hospital diabetes treatment related costs.
- 13 [PDF]
- B. AndersonM. Redondo
- 2011
Medicine
Journal of diabetes science and technology
Patient-reported outcome (PRO) evidence from pediatric and adult studies that compared insulin pen devices with vial and syringe use found that pens were considered less painful than syringes and were associated with less needle fear.
- 56
- PDF
- M. RahimiN. Izadi E. Rafiee
- 2016
Medicine
According to the results, mean levels of 25 (OH) D were significantly lower in diabetic patients than in healthy subjects, hence, check of vitamin D levels and supplementation with this vitamin is recommended in patients with diabetes.
- 7
...
...
Related Papers
Showing 1 through 3 of 0 Related Papers